Stockholm Bioregion Appoints CEO

Maj-Inger Nilsson, Associate Professor, has been appointed CEO of the
Stockholm BioRegion association. Dr. Nilsson has an extensive experience
from international pharmaceutical industry as well as from promoting and
funding EU research projects.

Stockholm BioRegion is an alliance constituted by the Karolinska
Institute, the City of Stockholm and AstraZeneca. Professor Hans Wigzell
is the chairman of Stockholm BioRegion and the association will
proactively promote and stimulate collaboration and networking between
academia, private companies and public organisations in biomedicine and
biotechnology.

For further information; please consult:www.stockholmbioregion.se or
contact CEO Maj-Inger Nilsson, phone: +46 8 508 280 14,
e-mail: